Serious concerns on the inability of FDG-PET in excluding residual viable lymphoma

Affiliations

¹ Department of Radiology and Nuclear Imaging, Deventer Hospital, Nico Bolkesteinlaan 75, Deventer, 7416 SE, The Netherlands. h.j.a.adams@gmail.com.
² Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Comment

Hugo J A Adams et al. Ann Hematol. 2018 May.

. 2018 May;97(5):915-916.

doi: 10.1007/s00277-018-3244-6. Epub 2018 Jan 12.

¹ Department of Radiology and Nuclear Imaging, Deventer Hospital, Nico Bolkesteinlaan 75, Deventer, 7416 SE, The Netherlands. h.j.a.adams@gmail.com.
² Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

No abstract available

Comment on

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.
Moskowitz AJ, Schöder H, Gavane S, Thoren KL, Fleisher M, Yahalom J, McCall SJ, Cadzin BR, Fox SY, Gerecitano J, Grewal R, Hamlin PA, Horwitz SM, Kumar A, Matasar M, Ni A, Noy A, Palomba ML, Perales MA, Portlock CS, Sauter C, Straus D, Younes A, Zelenetz AD, Moskowitz CH. Moskowitz AJ, et al. Blood. 2017 Nov 16;130(20):2196-2203. doi: 10.1182/blood-2017-06-788877. Epub 2017 Sep 5. Blood. 2017. PMID: 28874350 Free PMC article.